Jindal Saw Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 22, 2025, 9:16 pm

Quick Insight

Jindal Saw Ltd, operating in the Steel – Tubes/Pipes industry, exhibits promising financial indicators. With a current share price of 199 and a market capitalization of 12,722 Cr., the company boasts a P/E ratio of 8.73 and solid returns on equity (ROE) and capital employed (ROCE) at 13.7% and 19.4% respectively. Notably, the operating profit margin (OPM) stands at a healthy 15%, supported by a net profit of 1,458 Cr. The company's balance sheet shows strong reserves of 11,347 Cr. and a manageable debt level of ₹4,859 Cr., reflected in a comfortable interest coverage ratio (ICR) of 4.95x. With a diverse shareholder base and a price-to-book value (P/BV) ratio of 1.37x, Jindal Saw Ltd appears well-positioned for sustainable growth and value creation in the competitive steel sector.

Competitors of Jindal Saw Ltd

All Competitor Stocks of Jindal Saw Ltd

Quarterly Result

Last Updated: August 20, 2025, 8:35 am

Below is a detailed analysis of the quarterly data for Jindal Saw Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 4,085.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,047.00 Cr. (Mar 2025) to 4,085.00 Cr., marking a decrease of 962.00 Cr..
• For Expenses, as of Jun 2025, the value is 3,415.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4,310.00 Cr. (Mar 2025) to 3,415.00 Cr., marking a decrease of 895.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 670.00 Cr.. The value appears to be declining and may need further review. It has decreased from 736.00 Cr. (Mar 2025) to 670.00 Cr., marking a decrease of 66.00 Cr..
• For OPM %, as of Jun 2025, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Mar 2025) to 16.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 28.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 171.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 139.00 Cr. (Mar 2025) to 171.00 Cr., marking an increase of 32.00 Cr..
• For Depreciation, as of Jun 2025, the value is 153.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 153.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 374.00 Cr.. The value appears to be declining and may need further review. It has decreased from 473.00 Cr. (Mar 2025) to 374.00 Cr., marking a decrease of 99.00 Cr..
• For Tax %, as of Jun 2025, the value is -11.00%. The value appears to be improving (decreasing) as expected. It has decreased from 82.00% (Mar 2025) to -11.00%, marking a decrease of 93.00%.
• For Net Profit, as of Jun 2025, the value is 415.00 Cr.. The value appears strong and on an upward trend. It has increased from 87.00 Cr. (Mar 2025) to 415.00 Cr., marking an increase of 328.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 6.63. The value appears strong and on an upward trend. It has increased from 4.55 (Mar 2025) to 6.63, marking an increase of 2.08.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 5:06 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:53 am

Below is a detailed analysis of the balance sheet data for Jindal Saw Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 64.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 64.00 Cr..
• For Reserves, as of Mar 2025, the value is 11,347.00 Cr.. The value appears strong and on an upward trend. It has increased from 10,029.00 Cr. (Mar 2024) to 11,347.00 Cr., marking an increase of 1,318.00 Cr..
• For Borrowings, as of Mar 2025, the value is 4,859.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5,761.00 Cr. (Mar 2024) to 4,859.00 Cr., marking a decrease of 902.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 4,395.00 Cr.. The value appears to be improving (decreasing). It has decreased from 4,824.00 Cr. (Mar 2024) to 4,395.00 Cr., marking a decrease of 429.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 20,665.00 Cr.. The value appears to be improving (decreasing). It has decreased from 20,679.00 Cr. (Mar 2024) to 20,665.00 Cr., marking a decrease of 14.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 9,341.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,853.00 Cr. (Mar 2024) to 9,341.00 Cr., marking an increase of 488.00 Cr..
• For CWIP, as of Mar 2025, the value is 641.00 Cr.. The value appears strong and on an upward trend. It has increased from 632.00 Cr. (Mar 2024) to 641.00 Cr., marking an increase of 9.00 Cr..
• For Investments, as of Mar 2025, the value is 168.00 Cr.. The value appears to be declining and may need further review. It has decreased from 178.00 Cr. (Mar 2024) to 168.00 Cr., marking a decrease of 10.00 Cr..
• For Other Assets, as of Mar 2025, the value is 10,516.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11,016.00 Cr. (Mar 2024) to 10,516.00 Cr., marking a decrease of 500.00 Cr..
• For Total Assets, as of Mar 2025, the value is 20,665.00 Cr.. The value appears to be declining and may need further review. It has decreased from 20,679.00 Cr. (Mar 2024) to 20,665.00 Cr., marking a decrease of 14.00 Cr..

Notably, the Reserves (11,347.00 Cr.) exceed the Borrowings (4,859.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Jindal Saw Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 52.75. This value is within the healthy range. It has increased from 19.91 (Mar 23) to 52.75, marking an increase of 32.84.
• For Diluted EPS (Rs.), as of Mar 24, the value is 52.68. This value is within the healthy range. It has increased from 19.91 (Mar 23) to 52.68, marking an increase of 32.77.
• For Cash EPS (Rs.), as of Mar 24, the value is 67.60. This value is within the healthy range. It has increased from 28.58 (Mar 23) to 67.60, marking an increase of 39.02.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 292.94. It has increased from 227.62 (Mar 23) to 292.94, marking an increase of 65.32.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 292.94. It has increased from 227.62 (Mar 23) to 292.94, marking an increase of 65.32.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 655.42. It has increased from 558.79 (Mar 23) to 655.42, marking an increase of 96.63.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 109.12. This value is within the healthy range. It has increased from 57.66 (Mar 23) to 109.12, marking an increase of 51.46.
• For PBIT / Share (Rs.), as of Mar 24, the value is 91.36. This value is within the healthy range. It has increased from 42.94 (Mar 23) to 91.36, marking an increase of 48.42.
• For PBT / Share (Rs.), as of Mar 24, the value is 69.32. This value is within the healthy range. It has increased from 22.22 (Mar 23) to 69.32, marking an increase of 47.10.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 49.84. This value is within the healthy range. It has increased from 13.86 (Mar 23) to 49.84, marking an increase of 35.98.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 52.45. This value is within the healthy range. It has increased from 19.78 (Mar 23) to 52.45, marking an increase of 32.67.
• For PBDIT Margin (%), as of Mar 24, the value is 16.64. This value is within the healthy range. It has increased from 10.31 (Mar 23) to 16.64, marking an increase of 6.33.
• For PBIT Margin (%), as of Mar 24, the value is 13.93. This value is within the healthy range. It has increased from 7.68 (Mar 23) to 13.93, marking an increase of 6.25.
• For PBT Margin (%), as of Mar 24, the value is 10.57. This value is within the healthy range. It has increased from 3.97 (Mar 23) to 10.57, marking an increase of 6.60.
• For Net Profit Margin (%), as of Mar 24, the value is 7.60. This value is within the healthy range. It has increased from 2.48 (Mar 23) to 7.60, marking an increase of 5.12.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 8.00. This value is within the healthy range. It has increased from 3.53 (Mar 23) to 8.00, marking an increase of 4.47.
• For Return on Networth / Equity (%), as of Mar 24, the value is 16.61. This value is within the healthy range. It has increased from 7.98 (Mar 23) to 16.61, marking an increase of 8.63.
• For Return on Capital Employeed (%), as of Mar 24, the value is 23.00. This value is within the healthy range. It has increased from 13.44 (Mar 23) to 23.00, marking an increase of 9.56.
• For Return On Assets (%), as of Mar 24, the value is 7.97. This value is within the healthy range. It has increased from 3.46 (Mar 23) to 7.97, marking an increase of 4.51.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.20. This value is within the healthy range. It has decreased from 0.21 (Mar 23) to 0.20, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.55. This value is within the healthy range. It has decreased from 0.59 (Mar 23) to 0.55, marking a decrease of 0.04.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.07. It has increased from 1.02 (Mar 23) to 1.07, marking an increase of 0.05.
• For Current Ratio (X), as of Mar 24, the value is 1.24. This value is below the healthy minimum of 1.5. It has increased from 1.11 (Mar 23) to 1.24, marking an increase of 0.13.
• For Quick Ratio (X), as of Mar 24, the value is 0.64. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 23) to 0.64, marking an increase of 0.05.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.81. This value is below the healthy minimum of 4. It has decreased from 2.84 (Mar 23) to 2.81, marking a decrease of 0.03.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 5.68. This value is below the healthy minimum of 20. It has decreased from 10.04 (Mar 23) to 5.68, marking a decrease of 4.36.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 4.24. This value is below the healthy minimum of 20. It has decreased from 5.75 (Mar 23) to 4.24, marking a decrease of 1.51.
• For Earning Retention Ratio (%), as of Mar 24, the value is 94.32. This value exceeds the healthy maximum of 70. It has increased from 89.96 (Mar 23) to 94.32, marking an increase of 4.36.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 95.76. This value exceeds the healthy maximum of 70. It has increased from 94.25 (Mar 23) to 95.76, marking an increase of 1.51.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 4.95. This value is within the healthy range. It has increased from 2.89 (Mar 23) to 4.95, marking an increase of 2.06.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 3.26. This value is within the healthy range. It has increased from 1.73 (Mar 23) to 3.26, marking an increase of 1.53.
• For Enterprise Value (Cr.), as of Mar 24, the value is 17,782.55. It has increased from 8,481.50 (Mar 23) to 17,782.55, marking an increase of 9,301.05.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.84. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 23) to 0.84, marking an increase of 0.37.
• For EV / EBITDA (X), as of Mar 24, the value is 5.10. This value is within the healthy range. It has increased from 4.60 (Mar 23) to 5.10, marking an increase of 0.50.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.26 (Mar 23) to 0.65, marking an increase of 0.39.
• For Retention Ratios (%), as of Mar 24, the value is 94.31. This value exceeds the healthy maximum of 70. It has increased from 89.95 (Mar 23) to 94.31, marking an increase of 4.36.
• For Price / BV (X), as of Mar 24, the value is 1.37. This value is within the healthy range. It has increased from 0.58 (Mar 23) to 1.37, marking an increase of 0.79.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.26 (Mar 23) to 0.65, marking an increase of 0.39.
• For EarningsYield, as of Mar 24, the value is 0.12. This value is below the healthy minimum of 5. It has decreased from 0.13 (Mar 23) to 0.12, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness